TIMP2 and prostate carcinoma: The GT (TIMP-2 -418∗G/303∗T) haplotype was associated with an increased risk of prostate cancer (OR = 1.78; 95% CI: 1.18-2.69, P = 0.006, Pc = 0.024) [29].